Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.27 USD
Change Today -0.01 / -0.19%
Volume 342.7K
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael A. Sherman

Chief Financial Officer and Chief Operating Officer,Endocyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 3 different industries.

See Board Relationships
49$919,298
As of Fiscal Year 2014

Background*

Mr. Michael A. Sherman, also known as Mike, has been the Chief Financial Officer of Endocyte, Inc. since October 11, 2006 and has been its Chief Operating Officer since June 16, 2014. Mr. Sherman served as the Principal Accounting Officer of Endocyte, Inc., until May 26, 2011. Mr. Sherman served as a Director of Finance at Guidant Sales Corporation from March 1997 to March 2000. While at Guidant, he served several senior management positions, including Vice President ...

Read Full Background

Corporate Headquarters*

3000 Kent Avenue
West Lafayette, Indiana 47906

United States

Phone: 765-463-7175
Fax: 765-463-9271

Board Members Memberships*

2015-Present
Director, Member of Audit Committee and Member of Nutrition Science & Technology Committee

Education*

BA
DePauw University
MBA
Tuck School of Business at Dartmouth

Other Affiliations*

Annual Compensation*

Salary$322,985
Total Annual Compensation$322,985

Stock Options*

Restricted Stock Awards$83,325
All Other Compensation$6,130
Exercised Options14,927
Exercised Options Value$56,321
Exercisable Options191,309
Exercisable Options Value$428,200
Unexercisable Options182,500
Unexercisable Options Value$191,800
Total Value of Options$676,320
Total Number of Options388,736

Total Compensation*

Total Annual Cash Compensation$431,243
Total Short Term Compensation$322,985
Other Long Term Compensation$89,455
Total Calculated Compensation$919,298
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECYT:US $5.27 USD -0.01

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDOCYTE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.